BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 12682721)

  • 1. Effects of exogenous recombinant human granulocyte colony-stimulating factor (filgrastim, rhG-CSF) on neutrophils of critically ill patients with systemic inflammatory response syndrome depend on endogenous G-CSF plasma concentrations on admission.
    Weiss M; Voglic S; Harms-Schirra B; Lorenz I; Lasch B; Dumon K; Gross-Weege W; Schneider EM
    Intensive Care Med; 2003 Jun; 29(6):904-914. PubMed ID: 12682721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of a low-dosage Filgrastim (rhG-CSF) treatment in non-neutropenic surgical intensive care patients with an inflammatory process.
    Gross-Weege W; Weiss M; Schneider M; Wenning M; Harms B; Dumon K; Ohmann C; Röher HD
    Intensive Care Med; 1997 Jan; 23(1):16-22. PubMed ID: 9037635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of neutrophil function by in vivo filgrastim treatment for prophylaxis of sepsis in surgical intensive care patients.
    Weiss M; Gross-Weege W; Schneider M; Neidhardt H; Liebert S; Mirow N; Wernet P
    J Crit Care; 1995 Mar; 10(1):21-6. PubMed ID: 7538851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of recombinant human granulocyte colony-stimulating factor on neutrophil morphology, function and phenotype in patients with acute leukemia undergoing chemotherapy].
    Huang HH; Zhong JH; Han XF; Xuan ZH; Han JY; Chen FY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1033-7. PubMed ID: 16403274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Filgrastim (RHG-CSF) related modulation of the inflammatory response in patients at risk of sepsis or with sepsis.
    Weiss M; Gross-Weege W; Harms B; Schneider EM
    Cytokine; 1996 Mar; 8(3):260-5. PubMed ID: 8833041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actin polymerization in neutrophils from donors of peripheral blood stem cells: divergent effects of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor.
    Carulli G; Mattii L; Azzarà A; Brizzi S; Galimberti S; Zucca A; Benedetti E; Petrini M
    Am J Hematol; 2006 May; 81(5):318-23. PubMed ID: 16628714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo effect of recombinant human granulocyte colony-stimulating factor on phagocytic function and oxidative burst activity in septic neutropenic neonates.
    Ahmad M; Fleit HB; Golightly MG; La Gamma EF
    Biol Neonate; 2004; 86(1):48-54. PubMed ID: 15057022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats.
    Nohynek GJ; Plard JP; Wells MY; Zerial A; Roquet F
    Cancer Chemother Pharmacol; 1997; 39(3):259-66. PubMed ID: 8996530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.
    Kocherlakota P; La Gamma EF
    Pediatrics; 1997 Jul; 100(1):E6. PubMed ID: 9200380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of recombinant human granulocyte-colony stimulating factor to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and beta2 integrin expression. Results of a randomized controlled trial.
    Drossou-Agakidou V; Kanakoudi-Tsakalidou F; Sarafidis K; Taparkou A; Tzimouli V; Tsandali H; Kremenopoulos G
    Eur J Pediatr; 1998 Jul; 157(7):583-8. PubMed ID: 9686822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of granulocyte colony-stimulating factor treatment on ex vivo neutrophil functions in nonneutropenic surgical intensive care patients.
    Gerber A; Struy H; Weiss G; Lippert H; Ansorge S; Schulz HU
    J Interferon Cytokine Res; 2000 Dec; 20(12):1083-90. PubMed ID: 11152575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on respiratory burst activity of neutrophils in patients with myelodysplastic syndromes.
    Ohsaka A; Kitagawa S; Yuo A; Motoyoshi K; Furusawa S; Miura Y; Takaku F; Saito M
    Clin Exp Immunol; 1993 Feb; 91(2):308-13. PubMed ID: 7679062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased respiratory burst activity of neutrophils in patients with aplastic anemia: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.
    Ohsaka A; Kitagawa S; Yuo A; Motoyoshi K; Ohta M; Miura Y; Takaku F; Saito M
    Exp Hematol; 1992 Oct; 20(9):1090-3. PubMed ID: 1281785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia.
    Gillan ER; Christensen RD; Suen Y; Ellis R; van de Ven C; Cairo MS
    Blood; 1994 Sep; 84(5):1427-33. PubMed ID: 7520770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of endogenous and exogenous granulocyte colony-stimulating factor after autologous blood stem cell transplantation.
    Shimazaki C; Uchiyama H; Fujita N; Araki S; Sudo Y; Yamagata N; Ashihara E; Goto H; Inaba T; Haruyama H
    Exp Hematol; 1995 Dec; 23(14):1497-502. PubMed ID: 8542937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylcysteine reduces respiratory burst but augments neutrophil phagocytosis in intensive care unit patients.
    Heller AR; Groth G; Heller SC; Breitkreutz R; Nebe T; Quintel M; Koch T
    Crit Care Med; 2001 Feb; 29(2):272-6. PubMed ID: 11246305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor.
    Repp R; Valerius T; Sendler A; Gramatzki M; Iro H; Kalden JR; Platzer E
    Blood; 1991 Aug; 78(4):885-9. PubMed ID: 1714327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor differently modifies actin polymerization in neutrophils.
    Zucca A; Brizzi S; Riccioni R; Azzarà A; Ghimenti M; Carulli G
    Clin Ter; 2006; 157(1):19-24. PubMed ID: 16669548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and Pharmacodynamics of Two Formulations of Pegylated Recombinant Human Granulocyte Colony-Stimulating Factor in Healthy Chinese Subjects: An Open-Label, Randomized, Parallel-Design Bioavailability Study.
    Hu C; Ji B; Hu X; Yang C; Sun W; Zhao X; Li L; Li X; Zhang L
    Clin Pharmacol Drug Dev; 2021 Mar; 10(3):291-298. PubMed ID: 32567217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative treatment with filgrastim stimulates granulocyte function and reduces infectious complications after esophagectomy.
    Schäfer H; Hübel K; Bohlen H; Mansmann G; Hegener K; Richarz B; Oberhäuser F; Wassmer G; Hölscher AH; Pichlmaier H; Diehl V; Engert A
    Ann Hematol; 2000 Mar; 79(3):143-51. PubMed ID: 10803937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.